Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 44.82B | -2.06%45.49B | 2.55%183.85B | 6.66%47.72B | 8.68%46.45B | 2.05%179.28B | -0.27%47.56B | -3.10%44.23B | 7.55%44.75B | 4.90%42.74B |
| Cost of revenue | 38.2B | -3.54%38.8B | -0.22%157.14B | 1.96%40.6B | 6.85%40.22B | 2.24%157.48B | 1.02%41.13B | -4.28%38.88B | 4.92%39.82B | 8.35%37.65B |
| Gross profit | 6.62B | 7.50%6.7B | 22.51%26.71B | 44.69%7.13B | 22.18%6.23B | 0.69%21.8B | -7.78%6.44B | 6.44%5.34B | 34.82%4.93B | -15.03%5.1B |
| Operating expense | 7.42B | -3.36%7.71B | 1.02%33.16B | 13.57%8.77B | 18.85%7.98B | 19.86%32.82B | 53.12%11.03B | 4.06%7.36B | 25.90%7.72B | -3.75%6.72B |
| Operating profit | -806M | 41.95%-1.02B | 41.50%-6.45B | 41.21%-1.65B | -8.35%-1.75B | -92.32%-11.02B | -1,976.47%-4.59B | 1.76%-2.01B | -12.78%-2.8B | -65.51%-1.62B |
| Net non-operating interest income (expenses) | -559M | -78.63%-443M | 3.25%-1.13B | 17.33%-229M | 40.38%-248M | -6.86%-1.17B | 41.19%-217M | 19.31%-259M | -4.92%-277M | -197.14%-416M |
| Non-operating interest income | --43M | -72.27%33M | 108.46%271M | 78.13%57M | 815.38%119M | 170.83%130M | 260.00%54M | 444.44%31M | 23.08%32M | -18.75%13M |
| Non-operating interest expense | --602M | 29.70%476M | 7.93%1.4B | -7.44%286M | -14.45%367M | 13.75%1.3B | -29.43%271M | -7.05%290M | 6.55%309M | 175.00%429M |
| Net investment income | 232M | -148.71%-663M | 594.40%1.77B | -19.60%882M | 256.28%1.36B | 39.18%-357M | 12.50%-1.6B | -1,746.15%-240M | 271.86%1.1B | -60.00%382M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | 1.47B | -0.69%1.01B | 8.27%4.7B | 91.08%1.59B | -36.90%1.02B | 26.17%4.34B | -32.58%654M | -0.64%1.24B | 86.10%830M | 108.39%1.62B |
| Special income (charges) | -326M | 1,900.00%126M | -84.43%663M | -101.21%-6M | -101.13%-7M | 39.67%4.26B | 67.69%3.05B | -91.12%94M | 101.22%495M | 939.19%621M |
| Less:Restructuring and mergern&acquisition | --363M | --261M | 97.40%-151M | ---- | ---- | -55.55%-5.81B | -39.71%-4.53B | --0 | ---- | ---- |
| Less:Other special charges | --193M | -1,588.46%-387M | 114.81%290M | -53.33%7M | 52.94%26M | 162.50%135M | 174.90%197M | -4,800.00%-94M | 151.72%15M | -77.03%17M |
| Less:Write off | ---230M | --0 | -156.76%-802M | -100.13%-1M | 97.02%-19M | 57.00%1.41B | -23.89%1.28B | --0 | --767M | ---638M |
| Other non-operating income (expenses) | 358M | 15.90%277M | 741.50%943M | 34.97%193M | 334.55%239M | -146.96%-147M | -159.53%-409M | 131.53%64M | 221.19%143M | 203.77%55M |
| Income before tax | 366M | -214.45%-705M | 112.07%494M | 253.54%780M | -3.75%616M | -570.98%-4.09B | -394.60%-3.11B | -299.28%-1.11B | 72.91%-508M | 31.15%640M |
| Income tax | 276M | -28.09%215M | 335.96%1.05B | 52.28%501M | 110.56%299M | -141.82%-445M | -847.98%-1.29B | 8.00%378M | -21.29%329M | 15.45%142M |
| Net income | 91M | -390.54%-921M | 84.79%-555M | 133.25%278M | -36.35%317M | -117.92%-3.65B | -305.43%-1.82B | -137.52%-1.49B | 63.54%-836M | 36.81%498M |
| Net income continuous operations | --90M | -390.22%-920M | 84.76%-556M | 133.33%279M | -36.35%317M | -117.92%-3.65B | -305.78%-1.82B | -137.20%-1.49B | 63.50%-837M | 36.44%498M |
| Noncontrolling interests | 22M | 594.12%118M | 177.08%222M | 378.57%78M | 240.00%17M | -380.00%-288M | -22,900.00%-230M | -6.06%-35M | 0.00%-28M | 150.00%5M |
| Net income attributable to the company | 69M | -447.83%-1.04B | 76.87%-777M | 124.91%201M | -39.23%299M | -108.25%-3.36B | -279.21%-1.59B | -144.63%-1.46B | 64.34%-807M | 36.29%492M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 69M | -447.83%-1.04B | 76.87%-777M | 124.91%201M | -39.23%299M | -108.25%-3.36B | -279.21%-1.59B | -144.63%-1.46B | 64.34%-807M | 36.29%492M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 0.61 | -446.84%-9.33 | 76.85%-6.98 | 124.83%1.8 | -39.14%2.69 | -108.22%-30.15 | -279.22%-14.23 | -144.67%-13.09 | 64.32%-7.25 | 36.00%4.42 |
| Diluted earnings per share | 0.61 | -446.84%-9.33 | 76.85%-6.98 | 124.83%1.8 | -39.14%2.69 | -108.22%-30.15 | -279.23%-14.2306 | -144.67%-13.09 | 64.32%-7.25 | 36.00%4.42 |
| Dividend per share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |